Literature DB >> 10214762

Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients.

R Bakshi1, Z A Shaikh, V E Bates, P R Kinkel.   

Abstract

Clinical-neuroimaging analysis of 12 thrombotic thrombocytopenic purpura (TTP) patients revealed a variety of brain lesions. These included reversible cerebral edema lesions with MRI features of reversible posterior leukoencephalopathy syndrome (RPLS). Most of the RPLS patients had hypertension and renal dysfunction, suggesting RPLS due to hypertensive encephalopathy. Prompt treatment usually led to neurologic recovery and disappearance of edematous lesions. Those with infarcts or hematomas had a poorer outcome. TTP should be added to the expanding spectrum of RPLS and hypertensive encephalopathy.

Entities:  

Mesh:

Year:  1999        PMID: 10214762     DOI: 10.1212/wnl.52.6.1285

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

1.  A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke.

Authors:  Hakan Ozdogu; Can Boga; Ebru Kizilkilic; Mahmut Yeral; Ilknur Kozanoglu; Mehmet Karatas
Journal:  J Thromb Thrombolysis       Date:  2007-01-13       Impact factor: 2.300

2.  Suspicious neuroimaging pattern of thrombotic microangiopathy.

Authors:  T N Ellchuk; L M Shah; R H Hewlett; A G Osborn
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-03       Impact factor: 3.825

3.  Reversible posterior leukoencephalopathy syndrome in a patient with thrombotic thrombocytopenic purpura.

Authors:  Paolo Aridon; Paolo Ragonese; Maria Antonietta Mazzola; Gerlando Quintini; Marianna Lo Re; Simona Talamanca; Valeria Terruso; Marco D'Amelio; Giovanni Savettieri
Journal:  Neurol Sci       Date:  2011-01-14       Impact factor: 3.307

Review 4.  Spontaneous posterior fossa hemorrhage associated with low-molecular weight heparin in an adolescent recently diagnosed with posterior reversible encephalopathy syndrome: case report and review of the literature.

Authors:  Theofilos G Machinis; Kostas N Fountas; Vassilios G Dimopoulos; E Christopher Troup
Journal:  Childs Nerv Syst       Date:  2006-09-08       Impact factor: 1.475

5.  Tumor lysis syndrome as a contributory factor to the development of reversible posterior leukoencephalopathy.

Authors:  A Ozkan; B Hakyemez; F Ozkalemkas; R Ali; V Ozkocaman; T Ozcelik; O Taskapilioglu; Y Altundal; A Tunali
Journal:  Neuroradiology       Date:  2006-09-16       Impact factor: 2.804

6.  Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab.

Authors:  Keiichi Sumida; Yoshifumi Ubara; Junichi Hoshino; Tatsuya Suwabe; Rikako Hiramatsu; Eiko Hasegawa; Noriko Hayami; Masayuki Yamanouchi; Naoki Sawa; Fumi Takemoto; Kenmei Takaichi
Journal:  Clin Rheumatol       Date:  2010-03-12       Impact factor: 2.980

7.  [Postoperative occurrence of reversible posterior encephalopathy in a patient with Crohn's disease].

Authors:  S G Zipper; M Tischendorf; K Westphal
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

8.  The role of tumor lysis in reversible posterior leukoencephalopathy syndrome.

Authors:  Emiko Kaito; Satoshi Terae; Ryoji Kobayashi; Kohsuke Kudo; Khin Khin Tha; Kazuo Miyasaka
Journal:  Pediatr Radiol       Date:  2005-03-09

Review 9.  Seizures and epilepsy in cancer: etiologies, evaluation, and management.

Authors:  Jai Grewal; Harpreet K Grewal; Arthur D Forman
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

Review 10.  Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature.

Authors:  Hakan Gümüş; Hüseyin Per; Sefer Kumandaş; Ali Yikilmaz
Journal:  Neurol Sci       Date:  2009-10-07       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.